Skip to main content
Fig. 2 | Surgical and Experimental Pathology

Fig. 2

From: TGFβ1 pathway components in breast cancer tissue from aggressive subtypes correlate with better prognostic parameters in ER-positive and p53-negative cancers

Fig. 2

Immunostaining scores for TGFβ1 (a), TGFβRII (b) and p-SMAD2/3 (c) among BC molecular subtypes. Data is represented as the mean percentage of positive area in 3 fields analyzed per slide. Black lines represent the mean for each subtype. Dashed lines represent the mean for TGFβ1 (a; 6.253), TGFβRII (b; 6.294) and p-SMAD2/3 (c; 12.056) considering all BC samples. LB: Luminal-B-HER2+ subtype. HER2: HER2-enriched subtype. TN: triple-negative subtype

Back to article page